Ping An Smart Healthcare (PASH), a subsidiary of the Ping An Group (Ping An) in China, has rolled out its artificial intelligence (AI)-based medical decision support tool, or assistant, for doctors in Singapore.
The AI-based medical decision adviser known as AskBob was developed by Ping An and was launched in partnership with SingHealth and the National University Health System (NUHS).
Go deeper with GlobalData
Ping An said that AskBob provides critical and latest medical information to clinicians and help them to deal with patients at the point of care and for medical research and self-learning such as case discussions.
AskBob: A Smart Doctor Assistant
At the point of care situation, AskBob offers accurate diagnosis and treatment recommendations for more than 1,500 diseases.
Compared to other clinical decision support systems (CDSS), AskBob is a “knowledge + data” two-wheeled drive intelligent CDSS.
It is based on millions of patient medical records, clinical guidelines and a core medical knowledge graph with tens of millions of medical data, the company claims.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe treatment recommendations delivered by AskBob, according to Ping An, are authoritative, personalised and patient-centric.
For medical research and self-learning, AskBob leverages Ping An’s medical knowledge graph and advanced natural language processing technologies (NLP) to carry out intuitive and specific online searches, besides analysing the literatures.
AskBob can provide summaries of current literature analysis and foresee scientific research trends. Also, it can monitor the scholar team network in a certain research field to connect researchers worldwide.
SingHealth, one of Singapore’s largest public healthcare groups, partnered with Ping An in April 2019. It aims to offer doctors personalised treatment recommendations for type 2 diabetes patients at the point of care.
NUHS, the academic health sciences centre in Singapore, is currently trailing AskBob with clinicians for smart literature search and medical research trend analysis.
Ping An Group chief healthcare scientist Xie Guotong said: “We are delighted to cooperate with SingHealth and the National University Health System. They are both authoritative healthcare institutions in Singapore.
“With Ping An’s advanced healthcare technologies and through validating and customising AskBob with SingHealth and NUHS, we believe our smart decision support tool could effectively empower clinicians in Singapore, bringing better health outcomes for Singaporeans.”
SingHealth Duke-NUS Diabetes Centre head Bee Yong Mong said: “An AI-based clinical decision support system could potentially help doctors increase the accuracy and efficiency of diabetes treatment. With the tool, we hope to better predict risks of complications and offer more personalised treatment recommendations to patients.”
